Conference Coverage
Conference Coverage
Medicaid expansion closing racial gap in GI cancer deaths
Results of a new study were particularly notable for Black patients, for whom there was a consistent increase in receiving therapy and a decrease...
Latest News
Cross-border U.S.-Mexican collaboration drives up ALL survival
Conference Coverage
Chemo avoidance pays off for some women with HER2+ early BC
Almost all patients who skipped chemotherapy avoided invasive disease/death at 3 years.
Conference Coverage
Breast cancer: Meta-analysis supports ovarian suppression/ablation
Controlling estrogen seems to give premenopausal women a lifespan boost, but strategy remains uncommon.
Conference Coverage
SCLC: Bispecific antibody shows phase 1 promise
The antibody targets delta-like ligand 3, which is one of few surface markers for small cell lung cancer.
Conference Coverage
Surgical de-escalation passes clinical test in low-risk cervical cancer
‘Practice-changing’ results could reduce long-term survivor effects among qualifying patients.
Conference Coverage
Groundbreaking new regimen for advanced Hodgkin lymphoma
The immune checkpoint inhibitor nivolumab affords unprecedented improvement in “harmonizing” treatment for adult and pediatric Hodgkin lymphoma...
Conference Coverage
Minimally invasive vs. open surgery in pancreatic cancer
The results from this trial “will help both surgeons and patients feel comfortable that minimally invasive surgery, in expert hands, is not...
Conference Coverage
Unprecedented drop seen in early colorectal cancer cases due to aspirin use
The study confirms evidence from 30 years of research that suggests regular aspirin use reduces cancer risk.
Conference Coverage
'Paradigm shift’: Luspatercept for MDS
In a first head-to-head comparison study, luspatercept for MDS significantly outperformed epoetin alfa in reducing transfusion dependence.
Conference Coverage
Circulating tumor DNA may predict poor prognosis in breast cancer
Detection of ctDNA at any time point was associated with worse overall and disease-free survival in early breast cancer patients.